These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11754988)

  • 1. Postmortem studies of the effect of anti-inflammatory drugs on Alzheimer-type pathology and associated inflammation.
    Mackenzie IR
    Neurobiol Aging; 2001; 22(6):819-22. PubMed ID: 11754988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
    Pasinetti GM
    J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease.
    Breitner JC
    Annu Rev Med; 1996; 47():401-11. PubMed ID: 8712791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory drugs and Alzheimer-type pathology in aging.
    Mackenzie IR
    Neurology; 2000 Feb; 54(3):732-4. PubMed ID: 10680812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammatory mechanisms in the pathogenesis of Alzheimer's disease].
    Verbeek MM; Otte-Höller I; Ruiter DJ; de Waal RM
    Tijdschr Gerontol Geriatr; 1997 Oct; 28(5):213-8. PubMed ID: 9526791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
    Halliday G; Robinson SR; Shepherd C; Kril J
    Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal.
    Breitner JC
    Neurobiol Aging; 1996; 17(5):789-94. PubMed ID: 8892353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
    Klegeris A; McGeer PL
    Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory therapy for Alzheimer's disease.
    Aisen PS
    Neurobiol Aging; 2000; 21(3):447-8; discussion 451-3. PubMed ID: 10858592
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.
    Mackenzie IR; Munoz DG
    Neurology; 1998 Apr; 50(4):986-90. PubMed ID: 9566383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and Alzheimer's disease.
    Gupta A; Pansari K
    Int J Clin Pract; 2003; 57(1):36-9. PubMed ID: 12587940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease.
    McGeer PL; Rogers J
    Neurology; 1992 Feb; 42(2):447-9. PubMed ID: 1736183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
    Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
    Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
    Townsend KP; Praticò D
    FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and Alzheimer's disease pathogenesis.
    Rogers J; Webster S; Lue LF; Brachova L; Civin WH; Emmerling M; Shivers B; Walker D; McGeer P
    Neurobiol Aging; 1996; 17(5):681-6. PubMed ID: 8892340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches.
    Chen S; Frederickson RC; Brunden KR
    Neurobiol Aging; 1996; 17(5):781-7. PubMed ID: 8892352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
    Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
    Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease.
    O'Banion MK; Finch CE
    Neurobiol Aging; 1996; 17(5):669-71. PubMed ID: 8892338
    [No Abstract]   [Full Text] [Related]  

  • 19. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
    van Groen T; Miettinen P; Kadish I
    J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system.
    Pasinetti GM
    Neurobiol Aging; 1996; 17(5):707-16. PubMed ID: 8892343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.